← Human Trials & Peer-Reviewed Studies
Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial.
Plain-language guide to PMID 27060679 (2016): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 27060679
- Journal
- Allergy
- Year
- 2016
- Study type
- Randomized Controlled Trial
- Authors
- Grant CC et al. (9 authors)
- DOI
- 10.1111/all.12909
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Vitamin D has immune-modulating effects.
Who Took Part
By PubMed's age tags, the people studied were infants, both men and women.
When the children were 18 months old, the researchers measured serum-specific IgE antibodies and identified acute primary care visits described by the doctor to be due to a cold, otitis media, an upper respiratory infection, croup, asthma, bronchitis, bronchiolitis, a wheezy lower respiratory infection or fever and cough.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled and parallel-group study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
Groups ran in parallel: each of the participants stayed in one arm throughout.
A randomized, double-blind, placebo-controlled parallel-group trial.
What Was Measured
The subject headings attached to it are Allergens, Comorbidity, Dietary Supplements, Hypersensitivity, Hypersensitivity, Immediate, Immunoglobulin E and Maternal Exposure.
Author keywords: Vitamin D, 25-hydroxyvitamin D, asthma, infant, pregnancy and supplementation.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2016 (Allergy), a journal based in Denmark.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.